au.\*:("JHIANG, S. M")
Results 1 to 24 of 24
Selection :
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerMAZZAFERRI, E. L; JHIANG, S. M.The American journal of medicine. 1994, Vol 97, Num 5, pp 418-428, issn 0002-9343Conference Paper
Promoter characterization of the human Na+/I- symporterRYU, K.-Y; QIANG TONG; JHIANG, S. M et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 9, pp 3247-3251, issn 0021-972XArticle
The ret/PTC oncogene in papillary thyroid carcinomaJHIANG, S. M; MAZZAFERRI, E. L.The Journal of laboratory and clinical medicine. 1994, Vol 123, Num 3, pp 331-337, issn 0022-2143Article
The structure of the gene encoding chain c of the hemoglobin of the earthworm, Lumbricus terrestrisJHIANG, S. M; RIGGS, A. F.The Journal of biological chemistry (Print). 1989, Vol 264, Num 32, pp 19003-19008, issn 0021-9258Article
A novel multicolor hybridization scheme applied to localization of a transcribed sequence (D10S170/H4) and deletion mapping in the thyroid cancer cell line TPC-1JOSSART, G. H; O'BRIEN, B; CHENG, J.-F et al.Cytogenetics and cell genetics. 1996, Vol 75, Num 4, pp 254-257, issn 0301-0171Article
Exon-intron organization in genes of earthworm and vertebrate globinsJHIANG, S. M; GAREY, J. R; RIGGS, A. F et al.Science (Washington, D.C.). 1988, Vol 240, Num 4850, pp 334-336, issn 0036-8075Article
Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapySHEN, D. H. Y; MARSEE, D. K; SCHAAP, J et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 2, pp 161-169, issn 0969-7128, 9 p.Article
Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carconimaJHIANG, S. M; SMANIK, P. A; MAZZAFERRI, E. L et al.Cancer letters. 1994, Vol 78, Num 1-3, pp 69-76, issn 0304-3835Article
Thyroid peroxidase expression and DNA polymorphisms in thyroid cancerSMANIK, P. A; FITHIAN, L. J; JHIANG, S. M et al.Biochemical and biophysical research communications (Print). 1994, Vol 198, Num 3, pp 948-954, issn 0006-291XArticle
An STS in the human PTC oncogene located at 10qII.2JHIANG, S. M; ING-MING CHIU; MAZZAFERRI, E. L et al.Nucleic acids research. 1991, Vol 19, Num 15, issn 0305-1048, p. 4303Article
Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing Iodide transport defect in three Japanese patientsKOSUGI, S; INOUE, S; MATSUDA, A et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 9, pp 3373-3376, issn 0021-972XArticle
Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomasLA PERLE, K. M. D; JHIANG, S. M; CAPEN, C. C et al.The American journal of pathology. 2000, Vol 157, Num 2, pp 671-677, issn 0002-9440Article
Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glandsCHO, J.-Y; LEVEILLE, R; KAO, R et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 8, pp 2936-2943, issn 0021-972XArticle
Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic miceCHO, J.-Y; SAGARTZ, J. E; CAPEN, C. C et al.Oncogene (Basingstoke). 1999, Vol 18, Num 24, pp 3659-3665, issn 0950-9232Article
Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancerCASTRO, M. R; BERGERT, E. R; BEITO, T. G et al.Journal of endocrinology. 1999, Vol 163, Num 3, pp 495-504, issn 0022-0795Article
Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogeneSAGARTZ, J. E; JHIANG, S. M; TONG, Q et al.Laboratory investigation. 1997, Vol 76, Num 3, pp 307-318, issn 0023-6837Article
Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?BEYER, S. J; JIMENEZ, R. E; SHAPIRO, C. L et al.Breast cancer research and treatment. 2009, Vol 115, Num 1, pp 205-212, issn 0167-6806, 8 p.Article
Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinomaSMANIK, P. A; FURMINGER, T. L; MAZZAFERRI, E. L et al.Human molecular genetics (Print). 1995, Vol 4, Num 12, pp 2313-2318, issn 0964-6906Article
Cloning of the human taurine transporter and characterization of taurine uptake in thyroid cellsJHIANG, S. M; FITHIAN, L; SMANIK, P et al.FEBS letters. 1993, Vol 318, Num 2, pp 139-144, issn 0014-5793Article
Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene deliveryCHO, J.-Y; XING, S; LIU, X et al.Gene therapy (Basingstoke). 2000, Vol 7, Num 9, pp 740-749, issn 0969-7128Article
High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical picturesKOSUGI, S; SATO, Y; MATSUDA, A et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 11, pp 4123-4129, issn 0021-972XArticle
In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomasCHO, J.-Y; SHEN, D. H. Y; BARTH, R. F et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 17, pp 1139-1145, issn 0969-7128Article
Detection of the PTC/retTPC oncogene in human thyroid cancersJHIANG, S. M; CARUSSO, D. R; GILMORE, E et al.Oncogene (Basingstoke). 1992, Vol 7, Num 7, pp 1331-1337, issn 0950-9232Article
Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense constructPERLAKY, L; VALDEZ, B. C; BUSCH, R. K et al.Cancer research (Baltimore). 1992, Vol 52, Num 2, pp 428-436, issn 0008-5472Article
